" class="no-js "lang="en-US"> Austin L. Chiang - Medtech Alert
Thursday, March 30, 2023

Breaking News

Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Implantica Launches RefluxStop™ in Italy Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases Xeris Biopharma Appoints Ricki Fairley to Board of Directors AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson’s Disease New Imaging Method for Evaluating Transport of Oxygen to Blood Cells
Austin L. Chiang

Austin L. Chiang

About Austin L. Chiang

Related Story

Diseases

Medtronic Expands Health Equity Assistance Program for Colon Cancer Screening With Support From Amazon Web Services; Completes First Installation of Donated GI Genius™ Intelligent Endoscopy Modules

July 18 2022

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, and the American Society for Gastrointestinal Endoscopy (ASGE) today […]

Appointments

 Austin L. Chiang

Austin L. Chiang, M.D., M.P.H. joins Medtronic as Chief Medical Officer for Gastrointestinal Business

October 21 2021

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced Austin L. Chiang, M.D., M.P.H., […]